Dercum’s Disease Market | Industry Size, Phenomenal Growth, Booming Share

Market Research Future (MRFR) publishes periodic market research reports “Dercum’s Disease Market Research Report – Forecast to 2023” on niche and emerging technologies. For more information on our market research, please visit-

Market Summary:

Global Dercum’s Disease Research Report: by Treatment (Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies), by End-User (Hospital & Clinics, Others)– Forecast Till 2023

The global dercum’s disease market is anticipated to be growing due to factors such increasing expenditures in the healthcare sector in the developed as well as developing economies, growing occurrences of lipomas, increasing prevalence of rare diseases, and rising research and development activities. On the other hand, lack of awareness about the disease is likely to hamper the growth of the market over the forecast period.

Dercum’s disease is a rare pain syndrome characterized by chronically painful growths of fatty tissue or lipomas. These lipomas most commonly occur in the upper arms, upper legs, and trunk region. According to a report by the American Society of Interventional Pain Physicians in 2017, although women are most commonly affected by this condition, about 16% of the reported cases were in men. The common symptoms of this condition include painful fatty lipomas covering the body, obesity majorly in women in menopausal age, weakness, memory issues, elevated heart rate, joint aches, depression, and dementia. Currently, there is no cure for this condition and it is treated symptomatically with surgery, alternative therapies, and with medications such as non-steroidal anti-inflammatory drugs, diuretics, among others.

Key Players of the market

· Pfizer, Inc.,

· Abbvie, Inc.,

· Johnson & Johnson,

· GlaxoSmithKline Plc,

· Merck & Co., Inc.,

· Novartis,

· F. Hoffman,

· La Roche AG, Eli Lily and Company,

· AstraZeneca PLC,

· Amgen,

· Valeant Pharmaceuticals,

· Syneron Medical,

· St. Jude Medical Inc.

· Alimed, Inc

Global Dercum’s Disease Research Report: by Treatment (Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies), by End-User (Hospital & Clinics, Others)– Forecast Till 2023.To know more visit https://www.marketresearchfuture.com/reports/dercums-disease-market-6350

On the regional basis, the dercum’s disease market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the global dercum’s disease market, owing to the owing to the presence of a well-established healthcare segment, and increasing disposable income. Moreover, increasing funding for research and development by government fuels the market growth in this region.

Intended Audience

· Pharmaceutical Companies

· Research and Development (R&D) Companies

· Diagnostic Laboratories

· Government Research Institute

· Academic Institutes and Universities

Browse Other Related healthcare report

Blood Glucose Monitoring Market Research Report - Global Forecast till 2023

Surgical Lights Market Research Report - Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

https://www.marketresearchfuture.com